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Cytokines are important mediators of various aspects of health and disease, including 2 
appetite, glucose and lipid metabolism, insulin sensitivity, skeletal muscle hypertrophy and 3 
atrophy. Over the past decade or so, considerable attention has focused on the potential for 4 
regular exercise to counteract a range of disease states by modulating cytokine production. 5 
Exercise stimulates moderate to large increases in the circulating concentrations of 6 
interleukin (IL)-6, IL-8, IL-10, IL-1 receptor antagonist, granulocyte-colony stimulating factor, 7 
and smaller increases in tumor necrosis factor-, monocyte chemotactic protein-1, IL-1, 8 
brain-derived neurotrophic factor, IL-12p35/p40 and IL-15. Although many of these 9 
cytokines are also expressed in skeletal muscle, not all are released from skeletal muscle 10 
into the circulation during exercise. Conversely, some cytokines that are present in the 11 
circulation are not expressed in skeletal muscle after exercise. The reasons for these 12 
discrepant cytokine responses to exercise are unclear. In this review, we address these 13 
uncertainties by summarizing the capacity of skeletal muscle cells to produce cytokines, 14 
analyzing other potential cellular sources of circulating cytokines during exercise, and 15 
discussing the soluble factors and intracellular signaling pathways that regulate cytokine 16 
synthesis (e.g., RNA-binding proteins, microRNAs, suppressor of cytokine signaling proteins, 17 




Cytokines comprise a large family of polypeptides or proteins. This family includes 20 
interleukins, interferons, growth- and colony-stimulating factors, chemokines, members of 21 
the tumor necrosis factor group and transforming growth factors. Cytokines play an 22 
integrative and regulatory role as universal intercellular messengers. Once secreted, they 23 
can mediate intercellular communication locally or systemically. Alternatively, they can 24 
mediate intercellular contact even when bound to cell membranes (200). These 25 
characteristics distinguish cytokines from other intercellular messengers such as adhesion 26 
molecules, which require direct cell-to-cell contact, and hormones, which are produced by 27 
specialized endocrine organs and circulate throughout the body to exert their actions. Most 28 
cytokines are inducible mediators, are transported through the systemic circulation and are 29 
synthesized rapidly by multiple cell types in response to various stimuli. Individual cell types 30 
can express and secrete several cytokines simultaneously in response to a single stimulus 31 
(200). Cytokines are pleiotropic because they influence several cell types, and elicit different 32 
effects, depending on the type of target cells. They exert their pleiotropic actions in two 33 
phases. First, they bind to specific receptors expressed on cells with different origins and/or 34 
functions. Second, they mediate signal transduction through various intracellular 35 
messengers and transcription factors. The biological effects of cytokines depend on the 36 
presence and concentrations of other cytokines with synergistic, additive or counter-37 
regulatory actions (200). Cytokines can act in an autocrine, paracrine or endocrine fashion 38 
to induce or suppress their own synthesis and regulate the production of other cytokines 39 
and their receptors. They possess an important characteristic of self-limiting synthesis 40 
through various auto-regulatory mechanisms (e.g., RNA instability) and negative feedback 41 
pathways. These pathways include synthesis of eicosanoids and corticosteroid hormones, 42 
expression of soluble receptors, and induction of intracellular transcription factors that 43 
block signal transduction (200).  44 
The main function of cytokines is to regulate immune function. However, their wide-45 
ranging effects on cell proliferation, differentiation, migration, survival and apoptosis allow 46 
them to play a role in homeostatic control of various tissues, organs and systems. For 47 
example, together with hormones and neuropeptides, cytokines mediate interactions 48 
between the nervous, endocrine and immune systems. Some cytokines also control body 49 
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temperature, fatigue, appetite and metabolism. A link between cytokines and skeletal 50 
muscle was first established almost 50 years ago when researchers identified that an 51 
endogenous pyrogen was present in skeletal muscle (203). Cannon and Kluger (32) 52 
subsequently made another important discovery that endurance exercise induces the 53 
systemic release of a pyrogenic compound. These findings have since stimulated 54 
considerable interest in the biological significance and regulation of cytokine production in 55 
muscle during exercise and as a result of sepsis, aging, cancer cachexia and chronic 56 
inflammatory diseases.  57 
Initially, exercise research focused on the role of cytokines in mediating inflammatory 58 
responses to exercise-induced muscle damage. Evidence has accumulated over the past 59 
decade that cytokines play a much broader role during exercise. We now know that 60 
cytokines act in a hormone-like manner during exercise, mediating metabolism in working 61 
skeletal muscle, the liver and adipose tissue, angiogenesis and neurobiology (166). Following 62 
exercise, there is an increase in the circulating concentrations of assorted cytokines. Gene 63 
expression for some of these cytokines also increases within skeletal muscle. However, 64 
there appears to be a dissociation between local gene expression in skeletal muscle and the 65 
systemic concentration of other cytokines. For example, after exercise, tumor necrosis 66 
factor (TNF)- and interleukin (IL)-1 expression in skeletal muscle increases, but the 67 
circulating concentration of these cytokines does not change (or only increases slightly). 68 
Conversely, the circulating concentrations of IL-1 receptor antagonist (IL-1ra) and IL-10 69 
increase markedly, but these cytokines are not expressed in skeletal muscle after exercise.  70 
Several excellent reviews have discussed the evidence that skeletal muscle is a secretory 71 
organ (167, 168, 183, 232). Yet relatively few studies have specifically examined whether 72 
skeletal muscle cells themselves are the main source of cytokine gene expression in skeletal 73 
muscle during exercise. In this review, we examine this notion in more detail by (1) 74 
reviewing the findings from studies of cytokine expression and secretion in cultured skeletal 75 
muscle cells, and (2) summarizing the results of studies that have used histological staining 76 
of cytokine expression in cross-sections of muscle tissue. We also discuss other potential 77 
sources of cytokines both in skeletal muscle, other tissues and the systemic circulation. 78 
Most research to date has investigated the systemic factors and intracellular signaling 79 
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pathways that stimulate cytokine secretion by skeletal muscle cells. By contrast, much less is 80 
known about the factors that restrict or inhibit cytokine translation in skeletal muscle cells, 81 
and cytokine release into the circulation during exercise. We propose some potential 82 
negative regulatory mechanisms that may govern cytokine expression and secretion by 83 
skeletal muscle cells. Considering the important role of cytokines as local and systemic 84 
mediators of various aspects of health and disease, we contend that continuing research is 85 
needed to determine the dominant sources and regulation of cytokine production in the 86 
body. 87 
 88 
LOCAL AND SYSTEMIC CYTOKINE RESPONSES TO EXERCISE 89 
Numerous studies have investigated changes in the circulating concentrations of 90 
cytokines following exercise. Cytokine responses are generally dependent on the 91 
combination of mode, intensity, and duration of exercise. In the case of IL-6, prolonged 92 
running produces the greatest increase in plasma IL-6 concentration (167, 184). Indeed, 93 
circulating IL-6 can increase up to 120 following endurance exercise. IL-1ra (up to 90), IL-94 
10 (up to 80), IL-8 (15) and monocyte chemotactic protein (MCP-1) (up to 3) also 95 
consistently increase in the circulation following exercise (39, 64, 68, 102, 151-154, 164, 96 
165, 208, 212, 219, 225) (Table 1). There is substantial individual variability in the magnitude 97 
of changes in these cytokines in plasma after exercise (Figure 1).  98 
<Insert Figure 1 around here> 99 
Some of this variability appears to be related to variation in exercise intensity (156) and 100 
the extent of exercise-induced muscle damage (157, 228). By contrast, the plasma/serum 101 
concentrations of TNF- (4), brain-derived neurotrophic factor (BDNF) (2.5), IL-1 (2), IL-102 
12p40 (0.3), IL-15 (0.05) increase to a smaller extent, whereas leukemia inhibitory factor 103 
(LIF) and transforming growth factor (TGF)- remain unchanged following exercise (25, 29, 104 
39, 137, 153, 154, 186, 190, 220, 225). 105 
The gene expression of IL-1, IL-6, IL-8, IL-10, IL-15, TNF-, MCP-1, LIF and TGF- in 106 
skeletal muscle increases following endurance exercise (39, 64, 68, 82, 102, 124, 147, 151, 107 
152, 154, 208, 212) and resistance exercise (25, 50, 94, 124, 149, 150, 192) (Table 1). BDNF 108 
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mRNA expression also tends to increase (non-significantly) in response to endurance 109 
exercise (137). Similar to plasma cytokine responses, exercise-induced changes in cytokine 110 
gene expression in muscle can also be highly variable, possibly due to variation in single 111 
nucleotide polymorphisms within cytokine genes (52, 186). However, less is known about 112 
changes in the protein abundance of these cytokines in skeletal muscle after exercise. IL-6 113 
and BDNF protein expression increases in working skeletal muscle following endurance 114 
exercise (68, 89, 137), while the protein abundance of IL-6, IL-8 and MCP-1 also increases 115 
after resistance exercise (50, 51) and eccentric exercise (94). Changes in IL-1 are 116 
inconsistent (66, 129, 130), whereas IL-15 and LIF protein content does not change following 117 
exercise (25, 26, 130, 149).  118 
In contrast with pro-inflammatory cytokines, exercise-induced changes in the anti-119 
inflammatory cytokines IL-4 and IL-13 are less well characterized. We recently reported that 120 
IL-4 protein expression in muscle tended to decrease 2 h after resistance exercise in young 121 
men. However, following 12 weeks of resistance training, IL-4 protein expression increased 122 
when the same individuals performed another bout of resistance exercise (51). This finding 123 
suggests that IL-4 may play a role in muscular adaptations to training. In the same study, we 124 
observed that IL-13 protein expression in muscle did not change significantly after either 125 
bout of exercise (51). 126 
 127 
CYTOKINE EXPRESSION AND SECRETION BY SKELETAL MUSCLE CELLS 128 
Most of the evidence for cytokine expression in skeletal muscle is derived from the 129 
analysis of isolated RNA or protein extracts from homogenized muscle. However, muscle 130 
homogenates reflect contributions from intracellular, sequestered and interstitial sources of 131 
cytokines (23). This makes it difficult to identify specific cellular sources of cytokines in vivo. 132 
An extensive body of research has explored the capacity of skeletal muscle cells to produce 133 
cytokines in vitro by culturing skeletal muscle cells with various agents, and by subjecting 134 
skeletal muscle cells to cyclic strain and electromagnetic pulse stimulation (Table 2). 135 
<insert Table 2 near here> 136 
Evidence from cell culture studies 137 
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C2C12 myoblasts, L6 muscle cells and human myoblasts constitutively express IL-8 (47, 138 
133), IL-12 (72), IL-15 (180) and TGF- (72). Some, but not all studies report that myoblasts 139 
also constitutively express IL-1, IL-1ra, IL-6, TNF- and MCP-1 (17, 47, 70-73, 106, 133, 140 
144). Myoblasts do not express IL-10 or interferon (IFN)- (144). The constitutive expression 141 
of cytokines is generally stronger in differentiated myotubes compared with myoblasts (83, 142 
85, 86, 102, 107, 134, 144, 235) (Table 2).  143 
Myoblasts and myotubes express and secrete cytokines in vitro in response to a wide 144 
range of stimuli (Table 2). ATP, H2O2, xanthine/xanthine oxidase, nitric oxide and 145 
epinephrine are produced during exercise through redox reactions and autonomic nervous 146 
activity. These agents directly regulate the synthesis of cytokines by skeletal muscle cells by 147 
activating various signaling pathways (6, 70-72, 96, 107, 128, 235). The regulatory influence 148 
of TNF-, IL-1, IL-6, IFN-, TGF- and HSP60 is probably less direct, and depends on their 149 
relative concentration within the local microenvironment of skeletal muscle. Many of the 150 
agents listed above induce a concentration-dependent increase in the secretion of IL-6, IL-8, 151 
TNF- and MCP-1 (70, 72, 73, 85, 107, 134, 144). LPS, TNF-, IL-1, IL-6, IFN- and 152 
epinephrine also induce a time-dependent increase in the secretion of IL-6, TNF-, TGF- 153 
and MCP-1 for up to 48 hours (70-73, 133, 144). Human myotubes that undergo cyclic 154 
mechanical strain release IL-6, IL-8, MCP-1 and G-CSF (172). Mouse (62, 146, 235), rat (31) 155 
and human (25, 182, 195) myotubes that contract in response to electromagnetic pulse 156 
stimulation release a wide array of cytokines (Table 2). In addition to well characterized 157 
cytokines, the list of ‘contraction-responsive’ cytokines continues to grow (182, 195). 158 
The findings from cell culture studies provide important information on skeletal muscle 159 
cell secretion of cytokines in the context of trauma, sepsis or chronic inflammatory 160 
conditions. However, these findings are not necessarily applicable to understanding how 161 
skeletal muscle cells generate cytokines during exercise, for several reasons. The 162 
concentrations of most of the agents are most likely lower in skeletal muscle during exercise 163 
compared with the concentrations used in cell culture studies. The period for which skeletal 164 
muscle is exposed to these agents during exercise is also typically shorter than the 165 
incubation periods used in cell culture studies. Although epinephrine stimulates IL-6 mRNA 166 
expression and secretion (70), epinephrine appears to play a relatively minor role in 167 
regulating systemic changes in IL-6 during exercise (214). Last, cyclic strain and 168 
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electromagnetic pulse stimulation of myotubes do not fully reflect the dynamic conditions in 169 
skeletal muscle during exercise, where both stimulatory and inhibitory agents are present. 170 
Evidence from in vivo muscle analysis 171 
Human biopsy studies reveal that skeletal muscle expresses mRNA for numerous 172 
cytokines (Table 1) (25, 29, 83, 91, 94, 109, 149, 152, 154, 212). Mature myofibers make up 173 
most of the cellular mass within skeletal muscle, and as described in the previous section, 174 
myotubes express mRNA for various cytokines. Nevertheless, muscle homogenates 175 
represent a mixture of different types of cells; other inflammatory and stromal cells in 176 
skeletal muscle also secrete cytokines. Some research has used immunohistochemistry and 177 
immunofluorescence staining to examine the cellular sources of cytokines in healthy human 178 
muscle at rest (68, 89, 149, 175). Malm et al. (129) found that IL-6 and IL-1β are localized to 179 
both muscle and non-muscle cells. The same group subsequently reported that IL-6 180 
expression is low within skeletal muscle cells themselves, whereas it is expressed in the 181 
epimysium (130). In muscle of patients with inflammatory myopathies, cytokines are highly 182 
abundant, but are mainly localized to other cell types such as inflammatory T cells and 183 
macrophages, and in proximity to blood vessels in the endomysium and perimysium (46, 184 
194). Collectively, these findings demonstrate that cytokines are likely secreted by various 185 
cell types present in skeletal muscle, and not exclusively by skeletal muscle cells themselves. 186 
Surprisingly little research has used RNA in situ hybridization, immunohistochemistry or 187 
immunofluorescence staining to identify which fibers and resident cell types (e.g., 188 
endothelial cells, infiltrating leucocytes, satellite cells) in skeletal muscle produce cytokines 189 
in response to exercise. Table 3 summarizes the results of studies that have attempted to 190 
identify where cytokines are expressed in skeletal muscle after exercise or muscle 191 
contractions. Hiscock et al. (89) report that following endurance exercise, both IL-6 mRNA 192 
and protein are expressed mainly in type II fibers with high muscle glycogen content. They 193 
propose that the greater IL-6 expression in type II fibers may result from greater release of 194 
Ca2+ from the sarcoplasmic reticulum into the cytosol of the type II fibers (89). Following 195 
eccentric exercise, Hubal et al. (94) observed that MCP-1 is mainly expressed within the 196 
interstitial space between myofibers, and localizes with macrophages and Pax7+ satellite 197 
cells. Two studies have demonstrated that IL-6 also localizes with Pax7+ satellite cells in the 198 
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basal lamina of muscle fibers after eccentric exercise (138) and compensated hypertrophy 199 
(197). Following downhill running, Malm et al. (130) reported that IL-1 is mainly localized 200 
to non-muscle cells, whereas Fielding et al. (66) found that IL-1 is localized to the 201 
pericellular space. Using immunofluorescence staining for MCP-1 and IL-8, we recently 202 
reported that these chemokines are not present within mature myofibers after exercise. 203 
Rather, they are localized within the endomysium between muscle fibers and in close 204 
proximity to a number of cell types including macrophages, satellite cells and blood vessels 205 
(50). Hoier et al (90) investigated the subcellular localization of VEGF in muscle 2 h after 206 
cycling. They discovered that VEGF was located in the subsarcolemmal regions, between the 207 
contractile elements within the muscle fibers, and in pericytes positioned on the skeletal 208 
muscle capillaries. Lauritzen et al (116) conducted an elegant study in which they 209 
incorporated an enhanced green fluorescent protein tagged for IL-6 into muscle fibers 210 
isolated from the quadriceps muscles of mice. At rest, the fluorescent tag was localized in 211 
vesicular structures at the surface and in the interior of the transfected muscle fiber. 212 
Following in situ contractions of the fibers, the number of vesicles expressing the 213 
fluorescent tag decreased in both locations, indicating vesicular transport of IL-6 out of the 214 
fiber. These diverse findings highlight the need for more research to gain a better 215 
understanding of the local regulation and secretion of cytokines in muscle during exercise. 216 
<Insert Table 3 near here> 217 
 218 
DISSOCIATION BETWEEN LOCAL AND SYSTEMIC CYTOKINE RESPONSES TO EXERCISE 219 
 Curiously, although many cytokines are expressed in skeletal muscle following exercise, 220 
with the exception of IL-6, they are not released into the circulation—at least in large 221 
amounts (65, 68, 211, 212). In explanation of these observations, it has been suggested that 222 
some cytokines are produced locally by interstitial cells, and may not enter the circulation 223 
(130, 191). Catoire et al (37) recently conducted a systematic comparison of cytokine gene 224 
expression in muscle and plasma cytokine concentrations after one-legged 1 h cycling at 225 
60% heart rate reserve. They discovered that mRNA expression of IL-6, MCP-1, CXCL2 226 
(macrophage inflammatory protein-2) and CX3CL1 (fractalkine) was significantly 227 
upregulated. By contrast, mRNA expression of other cytokines including IL-7, IL-8, IL-15 and 228 
BDNF did not change significantly after exercise. Within plasma, MCP-1 and fractalkine 229 
increased after exercise, whereas IL-6 remained unchanged. This is the only study to report 230 
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simultaneous changes in MCP-1 and fractalkine within muscle and plasma following 231 
exercise. The finding that plasma IL-6 concentration did not change despite local expression 232 
in muscle may reflect the relatively small muscle mass and low intensity of exercise (37). An 233 
alternative explanation for the dissociation between local and systemic cytokine responses 234 
is that skeletal muscle may not secrete sufficient quantities of cytokines to increase their 235 
concentration in the systemic circulation. 236 
Although distinct from exercise, Borge et al. (23) conducted an elegant study to 237 
investigate whether cytokines are released systemically from skeletal muscle in response to 238 
lipopolysaccharide (LPS). Plasma and interstitial fluid were collected from mice 0.5, 1.5 and 239 
3 h after intravenous administration of 3.5 mg/kg LPS. The concentrations and kinetics of 240 
changes in cytokines were markedly different between interstitial fluid and plasma. The 241 
findings from this study by Borge et al. (23) provide important information about skeletal 242 
muscle as a source of circulating cytokines. The higher concentration of IL-1 in interstitial 243 
fluid compared with plasma suggests that although skeletal muscle cells produce IL-1, the 244 
systemic release of IL-1 from skeletal muscle is probably tightly regulated. The higher 245 
concentrations of TNF-, IL-10, MCP-1 in plasma compared with interstitial fluid 1.5 h after 246 
LPS infusion suggests that skeletal muscle is not a major source of these cytokines in the 247 
circulation. The smaller difference in the concentrations of IL-6 in plasma and interstitial 248 
fluid is consistent with other evidence that skeletal muscle releases IL-6 into the circulation 249 
during exercise (68, 211, 212). The time course of changes in the secretion of cytokines in 250 
this study is similar to that reported in plasma following exercise (160). The early secretion 251 
of TNF-α and IL-1β probably stimulated the sustained production of IL-6 (44, 71, 72, 125, 252 
162). Constitutive expression of IL-10 in skeletal muscle cells is low (144), but IL-10 253 
production may have increased in response to the early rise in TNF-α and IL-1β secretion 254 
(67). 255 
 256 
OTHER SOURCES OF LOCAL AND SYSTEMIC CYTOKINES DURING EXERCISE 257 
Cells within the microvasculature, namely endothelial cells and pericytes, are important 258 
regulators of angiogenesis and myogenesis, making them key players in both muscle and 259 
vascular generation following injury (2). Endothelial cells (78, 100, 111, 217, 238) and 260 
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pericytes secrete various cytokines (41, 108). Fibroblasts contribute to production of the 261 
extracellular matrix of muscle connective tissue by secreting fibronectin, laminin, specific 262 
tenascins and neural cell adhesion molecules (141). In response to muscle injury, fibroblasts 263 
proliferate and begin to produce collagen-rich extracellular matrix to restore the muscle’s 264 
framework (121). Fibroblasts also secrete assorted cytokines (47, 78, 118, 136, 163). 265 
Neutrophils play an important role in breaking down damaged muscle tissue in the acute 266 
phase of muscle injury (148, 174), whereas monocytes/macrophages regulate subsequent 267 
tissue regeneration (12, 218). Neutrophils (36, 58, 132, 187, 223) and 268 
monocytes/macrophages (8, 48, 54, 78, 93, 123, 131, 179) both secrete a variety of 269 
cytokines. As cytokine-producing cells, endothelial cells, pericytes, fibroblasts, neutrophils 270 
and monocytes/macrophages may all contribute to global cytokine expression in skeletal 271 
muscle. 272 
In addition to skeletal muscle, IL-6 is also released from the brain (158) and 273 
peritendinous tissue (114) after exercise. Whereas IL-6 mRNA is expressed in adipose tissue 274 
following exercise (45, 103), IL-6 is not released from adipose tissue during exercise (126). 275 
Evidence indicates that macrophages secrete IL-1 in the brain following downhill running 276 
(35), but it is unknown whether IL-1 is released from the brain into the circulation during 277 
exercise. Exercise also increases gene expression of IL-1ra and IL-15 receptor in the liver in 278 
fasting rats (30), but it remains unknown if the liver is a source of circulating cytokines after 279 
exercise. 280 
Leucocytes are probably only a minor source of circulating cytokines following exercise 281 
(Table 4). Studies on cytokine production by leucocytes can be divided into those that have 282 
measured cytokine gene expression in leucocytes, intracellular cytokine production, and 283 
extracellular cytokine secretion. Leucocyte mRNA expression of IL-1, IL-1ra, IL-8 and IL-10 284 
increases, whereas IL-6 mRNA expression remains unchanged after exercise (1, 20, 154, 285 
161). Monocyte intracellular cytokine production of IL-1, IL-6, TNF-, BDNF increases, 286 
decreases or remains unchanged following exercise (27, 185, 207, 209, 210). Extracellular 287 
cytokine secretion by mononuclear cells or in whole blood stimulated with LPS is also 288 
variable (1, 18, 19, 56, 57, 81, 87, 112, 173, 189, 202, 231). Fewer studies have investigated 289 
changes in cytokine expression or secretion by T lymphocytes following exercise. Two 290 
studies have reported that the number of IFN-+ T cells decreases after exercise, while the 291 
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number of IL-4+ T cells remains unchanged (113, 213). In contrast with these findings, 292 
Zaldivar et al (239) found that the percentage of T cells that expressed IL-4, IL-6 and TNF- 293 
increased following exercise. Kakanis et al (99) also observed that the secretion of both Th1 294 
cytokines (IL-2 and TNF-) and Th2 cytokines (IL-6, IL-10) by T cells stimulated with 295 
phytohemagglutinin increased after exercise. Work by La Voy et al (117) demonstrated that 296 
cytokine production during exercise may depend on changes in the numbers certain subsets 297 
of T cells. 298 
Skeletal muscle has been proposed as the dominant source of circulating IL-6 based on 299 
the increase in the arterial-femoral venous differences in the concentration of IL-6 (215). 300 
However, this does not provide prima facie evidence that skeletal muscle cells are the main 301 
cell type that secretes cytokines such as IL-6 into the circulation during exercise. Skeletal 302 
muscle is composed of many other cell types such as fibroblasts, myeloid cells, pericytes 303 
which also secrete cytokines. The organs and cells that secrete other cytokines (not 304 
produced in abundance by skeletal muscle cells) into the circulation during exercise remain 305 
to be determined. The results from many of these studies on cytokine secretion by 306 
leucocytes in vitro highlight the importance of how we interpret such data. It is important to 307 
consider differences in stimulated versus spontaneous cytokine secretion, intracellular 308 
cytokine production versus extracellular secretion, and changes in the absolute amount of 309 
cytokines that are secreted versus cytokine secretion per cell. 310 
< Insert Table 4 near here > 311 
 312 
REGULATION OF CYTOKINE SYNTHESIS AND SECRETION 313 
Cytokine secretion by skeletal muscle cells involves various intracellular factors, 314 
including mitogen-activated protein kinases, heat shock factor 1, histone deacetylases and 315 
transcription factors such as nuclear factor of activated T cells (NFAT), activating protein 316 
(AP)-1 and NFB (6, 70-72, 107, 128, 233, 235). In addition, cellular processes such as Ca2+ 317 
signaling and protein unfolding also stimulate muscle cells to express cytokine genes and/or 318 
secrete cytokines (92, 233). Activating transcription factor 3 is an important regulator of 319 
cytokine secretion by macrophages (76), and may also play a role in skeletal muscle cells. In 320 
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comparison with our knowledge of the factors that induce cytokine synthesis, much less is 321 
known about the factors that restrict and/or inhibit cytokine expression and secretion (145). 322 
In the context of exercise, this information is important because it could account for why IL-323 
1 and TNF- mRNA expression in skeletal muscle increases, yet the circulating 324 
concentrations of these cytokines remains comparatively low following exercise (150-152, 325 
212). Below, we propose some potential negative regulatory mechanisms that may govern 326 
cytokine expression and secretion by skeletal muscle cells. 327 
RNA-binding proteins 328 
Intracellular utilization of mRNA depends on several processes including mRNA 329 
maturation, shuttling and stability. In turn, these post-transcriptional processes are under 330 
the control of RNA-binding proteins and microRNAs. RNA-binding proteins regulate mRNA 331 
utilization by binding to adenine/uracyl-rich elements downstream of the 3’ untranslated 332 
regions of transcripts (205). A small subset of RNA-binding proteins are active in skeletal 333 
muscle, including human antigen R, KH-type splicing regulatory protein, CUG binding protein 334 
1, poly(A) binding protein, Lin-28 and tristetraprolin (9). These RNA-binding proteins are 335 
known to regulate myogenesis (9), but they may also control cytokine translation in skeletal 336 
muscle cells. Human antigen R enhances the stability of TNF- mRNA (49, 140). However, 337 
together with CUG binding protein 1 and tristetraprolin, human antigen R may also silence 338 
TNF- translation (33, 98, 101, 240). Tristetraprolin expression increases (221), whereas the 339 
expression of human antigen R decreases (181) in response to the anti-inflammatory 340 
cytokines IL-4 and IL-10.  341 
Relatively little research has examined changes in the expression of RNA-binding 342 
proteins in skeletal muscle following exercise. Hubal et al. (94) reported that mRNA 343 
expression of zinc finger protein 36 (a member of the tristetraprolin family) increases in 344 
skeletal muscle following exercise. This response is greater following eccentric exercise 345 
compared with concentric exercise, and is augmented following repeated bouts of eccentric 346 
exercise (94) which suggests a role for zinc finger protein 36 in regulating skeletal muscle 347 
adaptation following injury. Another study observed that tristetraprolin mRNA expression 348 
precedes that of LPS-inducible CXC chemokine mRNA expression in C2C12 myoblasts and in 349 
skeletal muscle following freeze injury (193). Geyer et al (75) performed an elegant study in 350 
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which they induced the expression of the RNA-binding protein tristetraprolin in C2C12 351 
myotubes. This treatment suppressed mRNA expression of MCP-1, KC (IL-8) and IL-6, while it 352 
also reduced MCP-1 secretion following LPS stimulation. These findings highlight the need 353 
for further research to gain greater insights into the role of RNA-binding proteins in 354 
regulating cytokine secretion by skeletal muscle cells. 355 
MicroRNAs 356 
 MicroRNAs also bind to the 3’ untranslated regions of transcripts (222) and interact with 357 
RNA-binding proteins to regulate the fate of mRNA (59, 98, 127). MicroRNAs such as Let-7, 358 
miR-146, miR-221, miR-155 and miR-106 regulate the expression of IL-1, IL-6, IL-8, TNF- 359 
and IL-10 by immune cells (21, 38, 59, 98, 170, 198, 224, 229). Skeletal muscle cells express 360 
a number of microRNAs, including miR-133, miR-1, miR-367, miR-135a, miR-222, miR-29a, b 361 
and c, miR-221, miR-223 and miR-206 (34, 42, 105). MicroRNA Let-7 inhibits the secretion of 362 
IL-13 in human myotubes (97). Other microRNAs such as miR-367, miR-222, and miR-29 may 363 
control cytokine secretion by skeletal muscle cells indirectly by altering the activity of 364 
endothelial nitric oxide synthase (188) and signal transducer and activator of transcription 365 
(STAT) proteins (53). As more microRNAs are identified in skeletal muscle, this may improve 366 
our knowledge of whether they regulate cytokine expression and secretion by skeletal 367 
muscle cells. 368 
 Suppressor of cytokine signaling (SOCS) 369 
 Surprisingly little research has investigated the role of SOCS proteins in regulating 370 
cytokine synthesis and signaling by skeletal muscle cells. Paradoxically, the limited evidence 371 
available indicates that overexpression of SOCS3 increases IL-6 transcription in myotubes 372 
(204). Under some conditions, the interaction between SOCS proteins and cytokines may be 373 
reciprocal. IL-6 and TNF- induce SOCS3 mRNA expression in C2 myoblasts (5) and cardiac 374 
myoblasts (230). TNF- infusion in vivo also stimulates SOCS3 mRNA in murine muscle (60). 375 
Further research is warranted to examine in greater detail the function of SOCS proteins as 376 
regulators of cytokine synthesis and signaling by skeletal muscle cells. 377 
Soluble receptors 378 
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 Soluble receptors can also restrict cytokine signaling through two main mechanisms. 379 
First, soluble receptors can act as a ‘non-signaling sink’ that directly competes with 380 
membrane-bound receptors for ligand binding. If the ligand-binding affinity of soluble 381 
receptors and membrane-bound receptors is similar, the capacity of soluble receptors to 382 
inhibit signaling depends on the balance between the two types of receptors (84). Soluble 383 
receptors for IL-1 and TNF- appear to operate in this manner (3, 10). Second, soluble 384 
receptors can arise through the proteolytic cleavage of membrane-bound receptors. This 385 
process results in fewer membrane-bound receptors to bind ligands and initiate cell 386 
signaling (84). TNF- and IL-6 can also induce shedding and/or endocytosis of their own 387 
receptors (55, 79, 88, 177). These actions may represent an autocrine negative feedback 388 
loop to prevent excess ligand stimulation. Currently, there is insufficient evidence to 389 
determine whether soluble receptors regulate cytokine signaling in skeletal muscle 390 
following exercise. Gene expression of soluble IL-6 receptor (but not gp130) is elevated in 391 
skeletal muscle between 4.5 and 9 h after exercise (104), whereas the plasma concentration 392 
of soluble IL-6 receptor does not change (104) or only increases slightly (120). The presence 393 
of circulating soluble IL-6 receptors after exercise may depend on proteolytic cleavage of IL-394 
6 receptors (120). Gene expression of TNF- and IL-1 in skeletal muscle is elevated for up 395 
to 24 h after exercise (124, 150-152). Although the plasma concentrations of soluble TNF- 396 
receptors and IL-1ra are also elevated for several hours after exercise (152, 160, 225), it is 397 
unknown whether these receptors are derived from, and are active in skeletal muscle. 398 
Other factors 399 
Other factors such as IL-6 and HSP72 produced locally in skeletal muscle during exercise 400 
may also regulate cytokine synthesis. IL-6 inhibits LPS-induced synthesis of TNF- by 401 
monocytes (196). In response to LPS treatment in vivo, TNF- concentration is lower in 402 
serum and broncho-alveolar lavage fluid from IL-6+/+ mice compared with IL-6-/- mice (236). 403 
An increase in plasma IL-6 concentration following IL-6 infusion or exercise inhibits the 404 
systemic release of TNF- in response to LPS (206). Local production of IL-6 may therefore 405 
regulate the synthesis and systemic release of TNF- during exercise.  406 
In addition to cytokines, endurance exercise induces HSP72 mRNA expression in skeletal 407 
muscle (16). Heat exposure increases HSP72 mRNA expression and IL-6 mRNA expression 408 
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and protein synthesis in C2C12 myotubes in a temperature-dependent manner (234). As 409 
further evidence for this regulatory role of HSP72, the heat shock inhibitor Knk437 410 
attenuates HSP72 mRNA expression, and completely blocks IL-6 mRNA expression in 411 
myotubes incubated at 42C (234). The interaction between HSP72 and IL-6 appears to be 412 
reciprocal, because IL-6 infusion induces HSP72 mRNA expression in skeletal muscle (63). 413 
Huey and Meador (95) demonstrated that IL-6 regulates the expression of HSPs in skeletal 414 
muscle in response to LPS, but not exercise. In direct contrast with IL-6, heat exposure 415 
inhibits TNF- mRNA expression in myotubes (234) and TNF- protein synthesis in other cell 416 
types (61, 142). These findings implicate HSP72 as a negative regulator of TNF- mRNA 417 
expression and synthesis, but further research is required to confirm this notion. The 418 
upstream regulator of HSPs, heat shock factor -1 may play a more central role than HSPs in 419 
regulating cytokine secretion by skeletal muscle cells (233). Ohno et al (159) have also 420 
demonstrated that acute heat stress suppresses NFB activity in C2C12 muscle cells. This 421 
response was accompanied by increased expression of HSP72 (159), but it remains to be 422 
determined if HSP72 can block NFB activity in muscle cells. 423 
Skeletal muscle expresses the gene for tumor necrosis factor receptor-associated factor 424 
(TRAF)-6-inhibitory zinc finger protein (TIZ) (77). By inhibiting the activation of NFB, c-Jun 425 
N-terminal kinase and AP-1 (199), zinc finger proteins such as TIZ may restrict cytokine 426 
secretion by skeletal muscle cells. Similar to other factors described above, future research 427 
could investigate the regulatory roles of zinc finger proteins in skeletal muscle.  428 
In another interesting study, Lee (119) demonstrated that treatment of C2C12 myotubes 429 
with IGF-1 inhibited mRNA expression of IL-6 and TNF-. This effect was due to suppression 430 
of TLR4 signaling, which was in turn mediated by inhibition of the PI3K/Akt signaling 431 
pathway (119). These findings provide further evidence of potential autocrine loops and 432 
cross-talk between cytokines and growth factors within skeletal muscle. 433 
Cytokine trafficking and secretion 434 
 In contrast with cells of the immune system, regulation of cytokine trafficking and 435 
secretion in muscle cells remains largely unknown. Hoier et al (90) made the first attempt to 436 
characterize the subcellular localization of VEGF in skeletal muscle. However, they did not 437 
investigate dynamic changes in trafficking of VEGF within muscle cells. Lauritzen et al (116) 438 
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have provided the most detailed insights to date on the mechanisms of cytokine secretion 439 
by skeletal muscle fibers. Stow and Murray (216) have provided a comprehensive overview 440 
on the mechanisms of trafficking and secretion in immune cells, and this may be used as a 441 
guide to new research in muscle cells. 442 
 443 
REGULATION OF CYTOKINE EXPRESSION AND SECRETION IN MYOBLASTS VERSUS 444 
MYOTUBES 445 
As noted previously, and summarized in Table 2, the constitutive expression of cytokines 446 
varies between myoblasts and myotubes. Below we discuss some of these differences, some 447 
of the mechanisms that may govern alterations in cytokine expression and secretion by 448 
skeletal muscle cells as they differentiate, and the possible biological significance of these 449 
differences.  450 
Gene expression of numerous chemokines and their receptors increases markedly after 451 
1648 h of differentiation (80). Of note, MCP-1 mRNA expression peaks at 16 h, whereas 452 
TNF- mRNA expression increases 10-fold between 16 and 24 h and declines thereafter 453 
(80). Several studies indicate that myoblasts and myotubes constitutively express similar 454 
levels of IL-6 mRNA. However, compared with myotubes, myoblasts produce substantially 455 
more IL-6 protein upon stimulation with IL-1, TNF- and LPS (71, 144, 178). In response to 456 
TNF- and LPS, myoblast production of IL-6 increases in a linear manner, whereas myotube 457 
production of IL-6 increases in a more ‘bell-shaped’ manner (178). The greater sensitivity of 458 
myoblasts to pro-inflammatory stimuli such as TNF- and LPS may reflect the requirement 459 
for myoblasts to secrete factors such as IL-6 to promote myoblast proliferation (13, 110), 460 
and therefore, muscle regeneration (178). Protein expression of MCP-1 (85), IL-6 (15) and 461 
LIF (25) also increases during the first 2448 h of differentiation. Protein expression of IL-7 462 
and IL-15 increases more steadily between 27 d of differentiation (83, 180). Protein 463 
expression of IL-1 and IL-1ra (14) and MCP-1 secretion (40) increase after 1216 d of 464 
differentiation. Gene and protein expression of BDNF decreases after 4 d (143). 465 
The factors responsible for changes in cytokine expression by skeletal muscle cells as 466 
they differentiate are uncertain. Some of the factors that regulate cytokine expression in 467 
18 
 
skeletal muscle cells (e.g., mitogen-activated protein kinases, histone deacetylases, NFAT 468 
and NFB) also control muscle cell differentiation (11, 15, 139, 169), and may therefore 469 
account for alterations in cytokine expression and secretion in skeletal muscle cells as they 470 
differentiate. The expression of some toll-like receptors (e.g., TLR2, TLR5) increases during 471 
muscle cell differentiation (24), which may also influence signaling pathways linked to 472 
cytokine expression and secretion in skeletal muscle cells (69). Changes in cytokine 473 
expression during muscle cell differentiation appear to play an important functional role. 474 
For example, increased expression of IL-6 (15) and reduced expression of BDNF (143) in 475 
skeletal muscle cells is necessary for them to differentiate. Conversely, increased expression 476 
of TNF- during muscle cell differentiation (80) may inhibit myoblast differentiation (115, 477 
227), although this effect is not entirely consistent (43). Using an RNAi screen, Ge et al (74) 478 
identified more than 100 cytokines that regulate myoblast differentiation. Based on their 479 
results, they were able to classify these cytokines according to their capacity to initiate 480 
differentiation, regulate myocyte fusion and inhibit differentiation. Increased chemokine 481 
expression during differentiation may also control the migration and/or positioning of 482 
myoblasts so that they can successfully fuse with nascent myotubes (80). Alternatively, 483 
increased cytokine expression during muscle cell differentiation may promote muscle cell 484 
proliferation (122, 237), and migration of monocytes (40) and mesenchymal stem cells (176) 485 
to support muscle growth. Last, autocrine cross-talk between cytokines may also control 486 
muscle cell differentiation (4, 7, 71, 125). 487 
 488 
CONCLUSION 489 
Our understanding of the importance of skeletal muscle and cytokines as mediators of 490 
metabolism has increased substantially over the last decade or so. Research to date has 491 
identified more than 600 different proteins that are secreted by skeletal muscle cells (168). 492 
In this rapidly advancing age of ‘-omics’ technologies, the muscle cell secretome will 493 
continue to grow and provide new targets on which to focus. We now know that myokines 494 
exert various endocrine effects on various metabolically active organs, including adipose 495 
tissue, the liver, the pancreas and the brain. Nevertheless, perhaps with the exception of IL-496 
6 and LIF, our knowledge of the factors and mechanisms that regulate cytokine production 497 
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and release from skeletal muscle cells during exercise remains somewhat limited. Skeletal 498 
muscle cells produce numerous cytokines in response to various agents, but not all these 499 
agents are present at similar concentrations and/or are active in the muscle 500 
microenvironment during exercise. The capacity for these individual agents to stimulate 501 
skeletal muscle cells to produce cytokines is well characterized. However, the control of 502 
cytokine production in skeletal muscle during exercise is more complex than the in vitro 503 
setting, and depends on interactions between a variety of local and systemic factors. Future 504 
research should aim to treat skeletal muscle cells with combinations and concentrations of 505 
agents that are present in skeletal muscle during exercise.  506 
Cyclic strain and electromagnetic stimulation of skeletal muscle myotubes in vitro has 507 
generated useful insights into the signaling pathways that govern cytokine production by 508 
skeletal muscle cells during exercise. Adding other factors—such as cytokines themselves—509 
to this experimental system could simulate the muscle microenvironment during exercise. In 510 
doing so, this approach may assist in characterizing interactions between factors that 511 
stimulate or inhibit the ability of skeletal muscle cells to produce cytokines during exercise.  512 
More research is warranted to identify the feedback mechanisms that govern cytokine 513 
synthesis by skeletal muscle cells; in particular, which mechanisms are most important, how 514 
they interact with each other, and how they are induced and regulated. These research 515 
endeavors are important for several reasons. First, this information may help to understand 516 
the factors governing the systemic release of cytokines. Second, this information may help 517 
to understand the processes that regulate acute inflammatory responses to tissue injury. 518 
Last, this information may help to determine why some pro-inflammatory cytokines are 519 
chronically elevated in skeletal muscle of patients with idiopathic myopathies, rheumatoid 520 
arthritis and muscular dystrophy. 521 
Finally, much has been written about the anti-inflammatory effects of exercise. Petersen 522 
et al (171) first proposed the notion that exercise-induced increases in IL-6, IL-1ra and IL-10 523 
exert beneficial anti-inflammatory effects to counteract obesity and insulin resistance. 524 
Although this theory is appealing from a mechanistic perspective (206), cytokines may play a 525 
relatively minor role in regulating the health benefits of exercise training. Evidence in 526 
support of this notion is that brisk walking does not stimulate any discernible increase in 527 
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circulating cytokines (135), yet regular walking is associated with many health benefits. 528 
Furthermore, marathon running induces high physiological stress and a large cytokine 529 
response (155), but it is doubtful the cytokines are increased for the purposes of health. 530 
Instead, exercise-induced cytokine changes may represent a more generalized response to 531 
internal and/or external stress. Factors such as oxidative or nitrosative stress, damaged or 532 
unfolded proteins, hyperthermia or energy imbalance likely induce cytokine production 533 
during exercise through catecholamines, endotoxin, alarmins, ATP and pro-inflammatory 534 
cytokines themselves (232). These issues highlight the need for further research to enhance 535 
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Table 1. Cytokine and chemokine expression in muscle and responses to 
mechanical strain and exercise. 
 Expression in 
human muscle 
Responsive to in vivo 
cyclic strain and EPS 






 mRNA protein mRNA protein mRNA protein  
IL-1         
IL-1ra         
IL-2         
IL-4         
IL-5    /     
IL-6         
IL-7    /     
IL-8         
IL-10  
(low) 
       
IL-12p35         
IL-13          
IL-15    /      
IL-18         
IFN-         
TNF-    / /    
MCP-1         
LIF         
VEGF    /     
BDNF         
TGF-         
uPA         
 or  indicate positive or negative evidence (respectively) of cytokine mRNA or 
protein expression/secretion in muscle and muscle contraction.  
 or  indicate an increase/decrease in plasma cytokine concentrations (more 
arrows denotes a greater increase).  indicates no increase in plasma cytokine 
concentrations. (Inclusion of two symbols indicates conflicting data.) 
N.B. Blank cells indicate no data are currently available. EPS, electromagnetic pulse 
stimulation. IFN, interferon; TNF, tumor necrosis factor; MCP, monocyte 
chemotactic protein; LIF, leukemia inhibitory factor; VEGF, vascular endothelial 
growth factor; BDNF, brain-derived neurotrophic factor; TGF, transforming growth 




Table 2. Expression of cytokines by skeletal muscle cells. 













 mRNA protein mRNA protein     
IL-1 H (low) /  H   H (low)  (late) TNF-   
IL-1ra C    H   LPS  + 
IL-4 H    H (low)     
IL-6 H /  
C  (low) 
H (low) 
C  
C  (low) H  
C  (low) 
 (early) LPS + + 
      TNF- + + 
      IL-1 + + 
      IFN-   
      TGF-   
      HSP60 +  
      H2O2 +  
      pyrogallol +  
      X/XO +  
      epinephrine + + 
      MG-132   
      AP-1   
      HSF-1   
      Dithiothreitol   
      Thapsigargin   
      Tunicamycin +  
      Castanospermine +  
      ATP  + 
IL-7   H (low) H (low)  LPS   
IL-8 H  H (low) H  H   TNF-   
      IFN-   
      IL-1   
      ‘Hyper IL-6’   
      LPS   
      HSP60 +  
IL-10 H    H (low)  TNF-   
IL-12    H (low)  LPS  + 
IL-13    H (low)  IGF-1   
IL-15    H   TNF-  + 
IL-17    H (low)     
IL-18  C         
TNF- H /  
C  (low) 
H   H (low)  (early) LPS + + 
      TNF-   
      IFN-   
MCP-1 H /  H     (early) LPS   
      TNF-   
      IFN-   
36 
 
      IL-1   
      ‘Hyper IL-6’ + + 
      HSP60 +  
LIF   H (low) H   (early) ionomycin   
IFN- H    H      
BDNF   C  C      
VEGF-A    H      
TGF- C    H   LPS   
      IL-1  + 
      TNF-  + 
      IFN-   
 indicates constitutive expression.  indicates no constitutive expression. H, human muscle cells. C, C2C12 
muscle cells. + indicates positive/additive response.  indicates no effect. N.B. Blank cells indicate no data 
are currently available. MCP-1, monocyte chemotactic protein-1; LIF, leukemia inhibitory factor; IFN, 
interferon. BDNF, brain-derived neutrophic factor; VEGF, vascular endothelial growth factor; TGF, 
transforming growth factor. LPS, lipolysaccharide; HSP, heat shock protein; X/XO, xanthine/xanthine oxidase; 
hyper IL-6, IL-6 covalently linked to soluble IL-6 receptor; MG-132, proteasome inhibitor; AP-1, activator 







Table 3. Cytokine localization in skeletal muscle after exercise. 
Cytokine Species Exercise 
mode 





IL-6 Humans Endurance Vastus 
lateralis 
 (type II fibers)  (89) 
IL-6* Rats Endurance Plantaris  (type I and IIa 
fibers) 
  
IL-6 Humans Eccentric Vastus 
lateralis 
  (satellite cells) (138) 
IL-6 Humans Eccentric Vastus 
lateralis 
low  (fibroblasts) (130) 
IL-6 Humans Eccentric Vastus 
lateralis 
low low (129) 
IL-6 Mice Eccentric Gastroc.   (inflammatory and 
satellite cells) 
(226) 
LIF Humans Eccentric Vastus 
lateralis 
  (endothelial cells) (130) 
IL-1 Humans Eccentric Vastus 
lateralis 
  (endothelial cells) (129) 
IL-1 Humans Eccentric Vastus 
lateralis 
  (129) 
IL-1 Humans Eccentric Vastus 
lateralis 
  (pericellular 
space) 
(66) 
MCP-1 Humans Eccentric Vastus 
lateralis 
  (macrophages and 
satellite cells) 
(94) 
MCP-1 Humans Resistance Vastus 
lateralis 
  (macrophages, 
satellite cells, blood 
vessels) 
(50) 
IL-8 Humans Resistance Vastus 
lateralis 
  (macrophages, 
blood vessels) 
(50) 





 (pericytes) (90) 
VEGF* Rats  Endurance Plantaris  (type IIb fibers)  (22) 
VEGF* Rats Endurance Gastroc.  (type I and IIa 
fibers) 
 (28) 
TGF-1 Rats Eccentric Gastroc.  (injured 
myofibers) 
 (201) 
















IL-1             
IL-1ra             
IL-6             
IL-8             
IL-10             
TNF-             
 or  indicate an increase/decrease in plasma cytokine concentrations (more arrows 
denotes a greater increase).  indicates no increase in plasma cytokine 
concentrations. (Inclusion of two symbols indicates conflicting data.). Unstimulated 
production refers to assays in which whole blood or cells were incubated with no 
external agent. Stimulated production refers to assays in which whole blood or cells 


































































































































































Figure 1. Individual variability in plasma cytokine responses to the Western States 160 km Endurance Run. 
Data indicate the change (in pg/ml) from pre- to post-exercise. Data are combined from Int J Sports Med 
24:541-547, 2003; Brain Beh Immun 19:398-403, 2005; Brain Beh Immun 20:578–584, 2006. 
